Results 141 to 150 of about 1,197 (161)
CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in Mice. [PDF]
Hoang-Phou S +12 more
europepmc +1 more source
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum. [PDF]
Takashima E +7 more
europepmc +1 more source
Unlocking the potential of blood-stage vaccines for malaria elimination. [PDF]
Nema S +3 more
europepmc +1 more source
Development of human mycoplasma vaccines: navigating the IL-17A paradox. [PDF]
Zhang W, Li T, Guo F.
europepmc +1 more source
Progress towards effective vaccines for Chlamydia trachomatis. [PDF]
Collar AL, Frietze KM.
europepmc +1 more source
Immunity to Sexually Transmitted Bacterial Infections of the Female Genital Tract: Toward Effective Vaccines. [PDF]
Yount KS, Darville T.
europepmc +1 more source
The emerging pathogen Candida auris: host interactions and disease drivers. [PDF]
Sanya DRA +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Pharmaceutics, 2022
Mucosal surfaces of the lungs represent a major site of entry for airborne pathogens, and pulmonary administration of vaccines is an attractive strategy to induce protective mucosal immunity in the airways. Recently, we demonstrated the potential of pulmonary vaccination with the tuberculosis subunit antigen H56 adjuvanted with the cationic liposomal ...
Olivia Amanda Oest Müllertz +4 more
openaire +3 more sources
Mucosal surfaces of the lungs represent a major site of entry for airborne pathogens, and pulmonary administration of vaccines is an attractive strategy to induce protective mucosal immunity in the airways. Recently, we demonstrated the potential of pulmonary vaccination with the tuberculosis subunit antigen H56 adjuvanted with the cationic liposomal ...
Olivia Amanda Oest Müllertz +4 more
openaire +3 more sources

